Submitted:
08 April 2024
Posted:
10 April 2024
You are already at the latest version
Abstract
Keywords:
Introduction
Material and Methods
Statistical Analysis
RESULTS
Descriptive Analysis
Multiple Regression Analysis of the Patient’s Sample
Discussion
| Scales | baseline, med (IIQ), min-max |
Six months later, med (IIQ), min-max |
Wilcoxon’s p-value with Bonferroni correction for multiple testing (14 tests) |
|---|---|---|---|
| HADS Depression | 9 (6; 10), 0 -15 | 8 (3; 9), 0 -14 | <0.001 |
| HADS Anxiety | 8 (5,8; 10), 1 -19 | 7 (3; 9), 2 -14 | <0.001 |
| MMS | 28 (26; 29), 11 -30 | 28,5 (27; 30), 15 -30 | <0.001 |
| CDT | 9 (6,9; 9,5), 1 -10 | 9,25 (7,9; 9,5), 1 -10 | 1 |
| UCLA loneliness scale | 36 (20; 45), 16 -62 | 33 (20; 41,3), 16 -60 | <0.001 |
| MAT | 5.86 (5.25; 6), 3.71-6 | 5.86 (5.43; 6), 3.71-6 | 1 |
| SF36v2 Physical functioning | 90 (65; 95), 10 -100 | 90 (70; 90), 10 -95 | 1 |
| SF36v2 Physical role | 100 (67,2; 100), 12,5 -100 | 100 (75; 100), 6,3 -100 | 0.010 |
| SF36v2 Pain | 74 (62; 91), 0 -100 | 84 (62; 100), 12 -100 | 0.238 |
| SF36v2 General health | 38,5 (25; 50,5), 15 -87 | 37,5 (28,8; 52), 10 -87 | 1 |
| SF36v2 Vitality | 37,5 (25; 62,5), 6,25 -93,75 | 43,75 (31,3; 56,3), 0 -87,5 | 1 |
| SF36v2 Social function | 56,2 (25; 87,5), 0 -100 | 62,5 (25; 90,6), 0 -100 | 0.007 |
| SF36v2 Emotional role | 75 (50; 100), 0 -100 | 91,67 (58,3; 100), 25 -100 | 0.001 |
| SF36v2 Mental health | 50 (35; 70), 5 -100 | 67,5 (50; 85), 15 -95 | <0.001 |
|
med-median; IIQ – interquartile range [1ºQ;3ºQ]; min-minimum; max-maximum; bold: significant p-values (p<0.05).
HADS: hospital anxiety and depression scale; MMS: mini-mental-state; CDT: clock drawing test; UCLALs: UCLA loneliness scale; MARS: medication adherence rating scale; B.I.; SF36-v2: short-form health survey - version 2. | |||
| Independent variables | Simple Linear Regression Model | Initial Multiple Model R[2]=0.362 F(16,97)=3.44, p <0.001 |
Final Multiple Model R2=0.325 F(4,109)=13.1, p<0.001 |
|||
|---|---|---|---|---|---|---|
| B [I.C. a 95%] | p-value | B [I.C. a 95%] | p-value | B [I.C. a 95%] | p-value | |
| Age | -1.21 [-2.34; -0.08] | 0.035 | -0.33 [-1.56;0.90] | 0.598 | ||
| Gender | ||||||
| Female | Reference | |||||
| Male | 7.32 [-6.93; 21.6] | 0.311 | ||||
| Schooling (in years) | 1.62 [-0.17; 3.42] | 0.076 | 0.13 [-2.03; 2.29] | 0.904 | ||
| HADS Depression | -0.54 [-3.45; 0.38] | 0.114 | -1.19 [-3.93; 1.55] | 0.390 | ||
| HADS Anxiety | -0.83 [-2.47; 0.81] | 0.318 | ||||
| MDMQ Self-esteem | 3.98 [1.97; 6.00] | <0.001 | ||||
| MDMQ Vigilance | 2.47 [0.80; 4.13] | 0.004 | 0.57 [-1.59; 2.73] | 0.601 | ||
| MDMQ Buck passing | -2.14 [-3.48; -0.80] | 0.002 | -0.18 [-2.13; 1.77] | 0.857 | ||
| MDMQ Procrastination | -3.90 [-5.69; -2.10] | <0.001 | ||||
| MDMQ Hypervigilance | -4.22 [-6.32; -2.13] | <0.001 | ||||
| NEO-FFI Neuroticism | -0.54 [-1.14; 0.06] | 0.079 | 0.29 [-0.87; 1.46] | 0.618 | ||
| NEO-FFI Extraversion | 0.48 [-0.39; 1.35] | 0.276 | ||||
| NEO-FFI Openness | 0.90 [0.14; 1.66] | 0.020 | 0.15 [-0.82; 1.12] | 0.762 | ||
| NEO-FFI Agreeableness | 1.60 [0.20; 2.99] | 0.025 | -0.35 [-1.87; 1.17] | 0.652 | ||
| NEO-FFI Conscientiousness | 2.15 [1.22; 3.09] | <0.001 | 1.65 [0.50; 2.81] | 0.005 | 1.65 [0.77; 2.54] | <0.001 |
| IRI Perspective taking | 25.92 [22.3; 29.51] | <0.001 | ||||
| IRI Empathic concern | 15.7 [7.26; 24.2] | <0.001 | 15.79 [6.46; 25.13] | 0.001 | 14.32 [6.19; 22.46] | <0.001 |
| IRI Personal distress | -6.89 [-13.1; -0.67] | 0.030 | -3.21 [-11.16; 4.74] | 0.425 | -6.01 [-11.78; -0.25] | 0.041 |
| IRI Fantasy | 11.3 [5.62; 16.9] | <0.001 | 5.54 [-1.41; 12.48] | 0.117 | 6.51 [1.15; 11.86] | 0.018 |
| UCLA | -0.37 [-0.80; 0.06] | 0.089 | -0.47 [-1.09; 0.16] | 0.145 | ||
| SF36v2 Physical functioning | 0.25 [-0.02; 0.52] | 0.069 | 0.11 [-0.41; 0.57] | 0.748 | ||
| SF36v2 Physical role | 0.10 [-0.13; 0.33] | 0.406 | ||||
| SF36v2 Pain | 0.09 [-0.19; 0.38] | 0.515 | ||||
| SF36v2 General health | -0.08 [-0.44; 0.28] | 0.645 | ||||
| SF36v2 Vitality | 0.20 [-0.08; 0.47] | 0.159 | 0.08 [-0.41; 0.57] | 0.748 | ||
| SF36v2 Social function | 0.15 [-0.04; 0.34] | 0.122 | -0.25 [-0.57; 0.08] | 0.133 | ||
| SF36v2 Emotional role | 0.13 [-0.09; 0.36] | 0.234 | ||||
| SF36v2 Mental health | 0.11 [-0.12; 0.38] | 0.296 | ||||
|
bold: significant p-values (p<0.05) HADS: hospital anxiety and depression scale; UCLALs: UCLA loneliness scale; YATEs: Yara attitude towards euthanasia scale; MDMQ: Melbourne decision-making questionnaire; NEO-FFI: NEO five-factor inventory; SF36-v2: short-form health survey - version 2; IRI: interpersonal reactivity index. | ||||||
Conclusion
Conflicts of Interest
References
- World Health Organization: WHO. Ageing and health. Published October 1, 2022. https://www.who.int/news-room/fact-sheets/detail/ageing-and-health.
- Population structure and ageing. Eurostat. Published May 16, 2023. https://ec.europa.eu/eurostat/statistics-explained/index.php?title=Population_structure_and_ageing.
- Projeções de População Residente. Statistics Portugal. Published March 31, 2020. https://www.ine.pt/xportal/xmain?xpid=INE&xpgid=ine_destaques&DESTAQUESdest_boui=406534255&DESTAQUESmodo=2&xlang=pt.
- Ismail Z, Ahmad WIW, Hamjah SH, Astina IK. The Impact of Population Ageing: A review. Iranian Journal of Public Health. Published online December 6, 2021. [CrossRef]
- Gao X, Geng T, Jiang M, et al. Accelerated biological aging and risk of depression and anxiety: evidence from 424,299 UK Biobank participants. Nature Communications. 2023;14(1). [CrossRef]
- Global, regional, and national burden of 12 mental disorders in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019. The Lancet Psychiatry. 2022;9(2):137-150. [CrossRef]
- Global health estimates: Leading causes of DALYs. https://www.who.int/data/gho/data/themes/mortality-and-global-health-estimates/global-health-estimates-leading-causes-of-dalys.
- De Sousa RD, Rodrigues AM, Gregório MJ, et al. Anxiety and depression in the Portuguese older adults: prevalence and associated factors. Frontiers in Medicine. 2017;4. [CrossRef]
- Chen J, Lin KP, Chen Y. Risk factors for dementia. Journal of the Formosan Medical Association. 2009;108(10):754-764. [CrossRef]
- Gao Y, Huang C, Zhao K, et al. Retracted: Depression as a risk factor for dementia and mild cognitive impairment: a meta-analysis of longitudinal studies. International Journal of Geriatric Psychiatry. 2012;28(5):441-449. [CrossRef]
- Santabárbara J, López-Antón R, De La Cámara C, et al. Clinically significant anxiety as a risk factor for dementia in the elderly community. Acta Psychiatrica Scandinavica. 2018;139(1):6-14. [CrossRef]
- Costa A, Feteira-Santos R, Alarcão V, et al. Health Literacy among Older Adults in Portugal and Associated Sociodemographic, Health and Healthcare-Related Factors. International Journal of Environmental Research and Public Health. 2023;20(5):4172. [CrossRef]
- População residente com 16 a 64 anos e 65 a 89 anos: por nível de escolaridade completo mais elevado (%). Statistics Portugal/PORDATA. Published February 10, 2023. https://www.pordata.pt/portugal/populacao+residente+com+16+a+64+anos+e+65+a+89+anos+por+nivel+de+escolaridade+completo+mais+elevado+(percentagem)-2266.
- Censos 2011. Statistics Portugal. Published November 20, 2012. https://censos.ine.pt/xportal/xmain?xpid=CENSOS&xpgid=ine_censos_indicador&contexto=ind&indOcorrCod=0006304&selTab=tab10.
- Brucki SMD. Illiteracy and dementia. Dementia & Neuropsychologia. 2010;4(3):153-157. [CrossRef]
- Maccora J, Peters R, Anstey KJ. What does (low) education mean in terms of dementia risk? A systematic review and meta-analysis highlighting inconsistency in measuring and operationalising education. SSM-Population Health. 2020;12:100654. [CrossRef]
- Sharp E, Gatz M. Relationship between education and dementia. Alzheimer Disease & Associated Disorders. 2011;25(4):289-304. [CrossRef]
- Erzen E, Çıkrıkçı Ö. The effect of loneliness on depression: A meta-analysis. International Journal of Social Psychiatry. 2018;64(5):427-435. [CrossRef]
- Owczarek M, Nolan E, Shevlin M, et al. How is loneliness related to anxiety and depression: A population-based network analysis in the early lockdown period. International Journal of Psychology. 2022;57(5):585-596. [CrossRef]
- Sundström A, Adolfsson AN, Nordin M, Adolfsson R. Loneliness increases the risk of All-Cause dementia and Alzheimer’s disease. The Journals of Gerontology: Series B. 2019;75(5):919-926. [CrossRef]
- Donovan NJ, Okereke OI, Vannini P, et al. Association of higher cortical amyloid burden with loneliness in cognitively normal older adults. JAMA Psychiatry. 2016;73(12):1230. [CrossRef]
- Vink D, Aartsen M, Schoevers RA. Risk factors for anxiety and depression in the elderly: A review. Journal of Affective Disorders. 2008;106(1-2):29-44. [CrossRef]
- Ladin K, Daniels N, Kawachi I. Exploring the relationship between absolute and relative position and Late-Life Depression: evidence from 10 European countries. The Gerontologist. 2009;50(1):48-59. [CrossRef]
- Dyer O, White C, Rada AG. Assisted dying: law and practice around the world. The BMJ. Published online August 19, 2015:h4481. [CrossRef]
- Steck N, Egger M, Maessen M, Reisch T, Zwahlen M. Euthanasia and assisted suicide in selected European countries and U.S. states. Medical Care. 2013;51(10):938-944. [CrossRef]
- Faria, Y. Relação entre atitude sobre eutanásia e crenças religiosas. Col:8875 | com:8874. 1986. https://bibliotecadigital.fgv.br/dspace/handle/10438/8928.
- Avci E. The goals of Medicine and Compassion in the ethical Assessment of Euthanasia and Physician-Assisted Suicide: Relieving pain and suffering by protecting, promoting, and maintaining the person’s Well-Being. Journal of Palliative Care. 2022;37(3):366-371. [CrossRef]
- Van Tol DG, Rietjens J, Van Der Heide A. Empathy and the application of the ‘unbearable suffering’ criterion in Dutch euthanasia practice. Health Policy. 2012;105(2-3):296-302. [CrossRef]
- Aghababaei N, Wasserman JA, Hatami J. Personality Factors and Attitudes toward Euthanasia in Iran: Implications for End-of-Life Research and Practice. Death Studies. 2013;38(2):91-99. [CrossRef]
- Dransart DAC, Lapierre S, Erlangsen A, et al. A systematic review of older adults’ request for or attitude toward euthanasia or assisted-suicide. Aging & Mental Health. 2019;25(3):420-430. [CrossRef]
- Wasserman JA, Aghababaei N, Nannini D. Culture, personality, and attitudes toward euthanasia. OMEGA - Journal of Death and Dying. 2015;72(3):247-270. [CrossRef]
- Rahimian Z, Rahimian L, Lopez-Castroman J, et al. What medical conditions lead to a request for euthanasia? A rapid scoping review. Health Sci Rep. 2024;7(3):e1978. [CrossRef]
- Evenblij K, Pasman HRW, Van Der Heide A, Hoekstra T, Onwuteaka-Philipsen BD. Factors associated with requesting and receiving euthanasia: a nationwide mortality follow-back study with a focus on patients with psychiatric disorders, dementia, or an accumulation of health problems related to old age. BMC Medicine. 2019;17(1). [CrossRef]
- Van Baarsen B. Suffering, Loneliness, and the Euthanasia Choice: An Explorative study. Journal of Social Work in End-of-Life & Palliative Care. 2009;4(3):189-213. [CrossRef]
- Doherty AM, Axe CJ, Jones DA. Investigating the relationship between euthanasia and/or assisted suicide and rates of non-assisted suicide: systematic review. BJPsych Open. 2022;8(4):e108. [CrossRef]
- Buiting H, Deeg DJH, Knol DL, et al. Older peoples’ attitudes towards euthanasia and an end-of-life pill in The Netherlands: 2001–2009. Journal of Medical Ethics. 2012;38(5):267-273. [CrossRef]
- Fritzsche DJ, Oz E. Personal values’ influence on the ethical dimension of decision making. Journal of Business Ethics. 2007;75(4):335-343. [CrossRef]
- Kemdal AB, Montgomery H. Perspectives and emotions in personal decision making. In: Routledge eBooks. ; 2002:86-103. [CrossRef]
- Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatr Scand. 1983;67(6):361-370. [CrossRef]
- Pais-Ribeiro J, Silva I, Ferreira T, Martins A, Meneses R, Baltar M. Validation study of a Portuguese version of the Hospital Anxiety and Depression Scale. Psychol Health Med. 2007;12(2):225-237. [CrossRef]
- Russell D, Peplau LA, Ferguson ML. Developing a measure of loneliness. J Pers Assess. 1978;42(3):290-294. [CrossRef]
- Pocinho, M.; Farate, C.; Dias, C. Validação Psicométrica da Escala UCLA-Loneliness para Idosos Portugueses. Interações: sociedade e novas modernidades 2010, 18. [Google Scholar]
- Delgado, A.; Lima, M. Contributo para a validação concorrente de uma medida de adesão aos tratamentos. Psicologia, Saúde & Doenças 2001, 2, 81–100. [Google Scholar]
- Mahoney, F.I.; Barthel, D.W. FUNCTIONAL EVALUATION: THE BARTHEL INDEX. Md State Med J. 1965, 14, 61–65. [Google Scholar] [PubMed]
- Araújo, F.; Pais-Ribeiro, J.; Oliveira, A.; Pinto, C. Validação do Índice de Barthel numa amostra de idosos não institucionalizados. Revista Portuguesa de saúde pública. 2007, 25, 59–66. [Google Scholar]
- Faria YS. Escala de atitude sobre eutanásia. Published 1988. https://bibliotecadigital.fgv.br/dspace/handle/10438/28192.
- Faria, Y. Atitude de médicos e advogados em relação à Eutanásia. Arquivos Brasileiros De Psicologia. 1989, 41, 44–61. [Google Scholar]
- Fonseca, L., Castro, L., Rego, G., Nunes, N. (2023). Cross-cultural adaptation and validation of an attitude about euthanasia scale in Portuguese older patients with mixed anxiety-depressive disorder. Acta Medica Portuguesa. Under Revision.
- Wasserman JA, Clair JM, Ritchey FJ. A Scale to Assess Attitudes toward Euthanasia. OMEGA - Journal of Death and Dying. 2005;51(3):229-237. [CrossRef]
- Unpublished master’s thesis: Rosa, C., & Gouveia, M. Atitudes perante a eutanásia e ansiedade perante a morte numa amostra de estudantes universitários. Lisbon. Instituto Universitário de Ciências Psicológicas, Sociais e da Vida. 2015.
- Mann, L.; Burnett, P.; Radford, M.; Ford, S. The Melbourne Decision Making Questionnaire: An instrument for measuring patterns for coping with decisional conflict. Journal of Behavioral Decision Making. 1997, 10, 1–19. [Google Scholar] [CrossRef]
- Filipe L, Alvarez M, Roberto MS, Ferreira JA. Validation and invariance across age and gender for the Melbourne Decision-Making Questionnaire in a sample of Portuguese adults. Judgment and Decision Making. 2020;15(1):135-148. [CrossRef]
- Costa PT, McCrae RR. Revised NEO Personality Inventory (NEO PI-R) and NEO Five-Factor Inventory (NEO-FFI). 1992.
- Magalhães E et al. NEO-FFI: Psychometric properties of a short personality inventory in Portuguese context. Psicologia: Reflexão E Crítica. 2014;27(4):642-657. [CrossRef]
- Davis, M.A. Multidimensional Approach to Individual Differences in Empathy. Journal of Personality and Social Psychology. 1980, 10, 85. [Google Scholar]
- Limpo, T.; Alves, R.; Castro, S. Medir a empatia: Adaptação portuguesa do Índice de Reactividade Interpessoal. Laboratório De Psicologia. 2010, 8, 171–184. [Google Scholar] [CrossRef]
- Ware, J.E., Jr.; Sherbourne, C.D. The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care. 1992, 30, 473–483. [Google Scholar] [CrossRef] [PubMed]
- Ferreira, P.L. Criação da versão portuguesa do MOS SF-36. Parte I – Adaptação cultural e linguística. Acta Med Port. 2000, 13, 55–66. [Google Scholar] [PubMed]
- Ferreira, P.L. Criação da versão portuguesa do MOS SF-36. Parte II – Testes de validação. Acta Med Port. 2000, 13, 119–127. [Google Scholar] [PubMed]
- Kutcher S, Chehil S. Suicide risk management: A manual for health professionals. Malden, MA: Blackwell Publishing Ltd; 2007.
- Folstein MF, Folstein SE, McHugh PR. “Mini-mental state.” Journal of Psychiatric Research. 1975;12(3):189-198. [CrossRef]
- Unpublished doctoral dissertation: Guerreiro, M. Contributo da Neuropsicologia para o Estudo das Demências. Lisbon. University of Lisbon. 1998.
- Cacho, J.; García-García, R.; Arcaya, J.; Vicente, J.L.; Lantada, N. Una propuesta de aplicación y puntuación del test del reloj en la enfermedad de Alzheimer [A proposal for application and scoring of the Clock Drawing Test in Alzheimer's disease]. Revista de neurología. 1999, 28, 648–655. [Google Scholar] [CrossRef] [PubMed]
- Rouleau I, Salmon DP, Butters N, Kennedy CM, McGuire K. Quantitative and qualitative analyses of clock drawings in Alzheimer’s and Huntington’s disease. Brain and Cognition. 1992;18(1):70-87. [CrossRef]
- Santana I, Duro D, Lemos R, et al. Mini-Mental State Examination: Avaliação dos Novos Dados Normativos no Rastreio e Diagnóstico do Défice Cognitivo. Acta Médica Portuguesa. 2016;29(4):240-248. [CrossRef]
- Santana I, Duro D, Freitas S, Alves LB, Simões MR. The Clock Drawing Test: Portuguese norms, by age and education, for three different scoring systems. Archives of Clinical Neuropsychology. 2013;28(4):375-387. [CrossRef]
- Goodglass, H. and Kaplan, E. (1972) The Assessment of aphasia and Related Disorders. Lea & Febiger, Philadelphia.
- Kaplan E.. Bull T., Bryant B. K. A process approach to neuropsychological assessment, Clinical neuropsychology and brain function: Research, measurement, and practice, 1988Washington, DCAmerican Psychological Association(pg. 129-167).
- Condições em que a morte medicamente assistida não é punível Act 22, 2023 (Portugal).
- Calcedo-Barba A, Fructuoso A, Martínez-Raga J, Paz S, De Carmona MS, Vicens E. A meta-review of literature reviews assessing the capacity of patients with severe mental disorders to make decisions about their healthcare. BMC Psychiatry. 2020;20(1). [CrossRef]
- Kotzé C, Roos JL. Ageism, human rights and ethical aspects of end-of-life care for older people with serious mental illness. Frontiers in Psychiatry. 2022;13. [CrossRef]
- Van Der Geest S, Satalkar PP. Autonomy and dying: Notes about decision-making and “completed life” euthanasia in the Netherlands. Death Studies. 2019;45(8):613-622. [CrossRef]
- Flynn, K.; Smith, M. Personality and health care decision-making style. The journals of gerontology. Series B, Psychological sciences and social sciences 2007, 62, 261–267. [Google Scholar] [CrossRef] [PubMed]
- Othman RE, Othman RE, Hallit R, Obeïd S, Hallit S. Personality traits, emotional intelligence and decision-making styles in Lebanese universities medical students. BMC Psychology. 2020;8(1). [CrossRef]
- Skagerlund K, Forsblad M, Tinghög G, Västfjäll D. Decision-making competence and cognitive abilities: Which abilities matter? Journal of Behavioral Decision Making. 2021;35(1). [CrossRef]
- Fenton L, Han SD, DiGuiseppi CG, et al. Mild Cognitive Impairment is Associated with Poorer Everyday Decision Making. J Alzheimers Dis. 2023;94(4):1607-1615. [CrossRef]
- Fonseca L, Monteleone F, Gonçalves A, Rêgo G, Nunes R. Decision-Making Capacity of Elderly Patients with Mixed Depression-Anxiety Disorder. Acta Médica Portuguesa. Published online April 12, 2023. [CrossRef]
- Verhofstadt M, Van Assche K, Sterckx S, Audenaert K, Chambaere K. Psychiatric patients requesting euthanasia: Guidelines for sound clinical and ethical decision making. International Journal of Law and Psychiatry. 2019;64:150-161. [CrossRef]
- Biro D. Is There Such a Thing as Psychological Pain? and Why It Matters. Culture, Medicine and Psychiatry. 2010;34(4):658-667. [CrossRef]
- Dees M, Vernooij-Dassen MJFJ, Dekkers W, Van Weel C. Unbearable suffering of patients with a request for euthanasia or physician-assisted suicide: an integrative review. Psycho-Oncology. 2010;19(4):339-352. [CrossRef]
- Verhofstadt M, Thienpont L, Peters GJ. When unbearable suffering incites psychiatric patients to request euthanasia: qualitative study. The British Journal of Psychiatry. 2017;211(4):238-245. [CrossRef]
- Trachsel M, Jox RJ. Suffering is not enough: Assisted dying for people with mental illness. Bioethics. 2022;36(5):519-524. [CrossRef]
- Newson JJ, Hunter D, Thiagarajan TC. The Heterogeneity of Mental Health Assessment. Front Psychiatry. 2020;11:76. Published 2020 February 27. [CrossRef]
- Lake J, Turner MS. Urgent need for improved mental health care and a more collaborative model of care. The Permanente Journal. 2017;21(4). [CrossRef]
- Carvajal C. Poor response to treatment: beyond medication. Dialogues in Clinical Neuroscience. 2004;6(1):93-103. [CrossRef]
- Howes O, Thase ME, Pillinger T. Treatment resistance in psychiatry: state of the art and new directions. Molecular Psychiatry. 2021;27(1):58-72. [CrossRef]
- McKee K, Schüz B. Psychosocial factors in healthy ageing. Psychology & Health. 2015;30(6):607-626. [CrossRef]
- Fuchs T. Subjectivity and intersubjectivity in psychiatric diagnosis. Psychopathology. 2010;43(4):268-274. [CrossRef]
- Van Veen S, Widdershoven G, Beekman A, Evans N. Physician Assisted Death for Psychiatric Suffering: Experiences in the Netherlands. Frontiers in Psychiatry. 2022;13. [CrossRef]
- 90. Van Den Berg V, Zomers M, Van Thiel GJMW, Leget C, Van Delden JJM, Van Wijngaarden E. Requests for euthanasia or assisted suicide of people without (severe) illness. Health Policy. [CrossRef]
- 91. Hartog ID, Zomers M, Van Thiel GJMW, et al. Prevalence and characteristics of older adults with a persistent death wish without severe illness: a large cross-sectional survey. BMC Geriatrics. [CrossRef]
- Dierickx S, Deliëns L, Cohen J, Chambaere K. Euthanasia for people with psychiatric disorders or dementia in Belgium: analysis of officially reported cases. BMC Psychiatry. 2017;17(1). [CrossRef]
- Jones DF, Gastmans C, MacKellar C. Euthanasia and assisted suicide.; 2017. [CrossRef]
- Meyer J, Lüdtke O, Schmidt FTC, Fleckenstein J, Trautwein U, Köller O. Conscientiousness and cognitive ability as predictors of academic achievement: evidence of synergistic effects from integrative data analysis. European Journal of Personality. 2022;38(1):36-52. [CrossRef]
- Namba S, Kabir RS, Matsuda K, et al. Fantasy Component of Interpersonal Reactivity is Associated with Empathic Accuracy: Findings from Behavioral Experiments with Implications for Applied Settings. Reading Psychology. 2021;42(7):788-806. [CrossRef]
| Patients (n=114) | Controls (n=25) | |
|---|---|---|
| Gender, n (%) | ||
| Female | 87 (76.3) | 11 (44) |
| Male | 27 (23.7) | 14 (56) |
| Age (years), mean±sd, min-max | 73.01 ± 5.319, 65-91 | 71.84 ± 3.287, 66-78 |
| Years of school, n (%) | ||
| 0 | 7 (6.1) | 0 (0) |
| 1 | 2 (1.8) | 0 (0) |
| 2 | 1 (0.9) | 0 (0) |
| 3 | 13 (11.4) | 1 (4) |
| 4 | 70 (61.4) | 10 (40) |
| 5 | 0 (0) | 1 (4) |
| 6 | 5 (4.4) | 1 (4) |
| 7 | 1 (0.9) | 1 (4) |
| 8 | 1 (0.9) | 1 (4) |
| 9 | 3 (2.6) | 1 (4) |
| 11 | 2 (1.8) | 0 (0) |
| 12 | 4 (3.5) | 3 (12) |
| 15 | 2 (1.8) | 2 (8) |
| 16 | 1 (0.9) | 0 (0) |
| 17 | 2 (1.8) | 4 (16) |
| Civil status, n (%) | ||
| Married | 69 (60.5) | 21 (84) |
| Divorced | 12 (10.5) | 1 (4) |
| Single | 7 (6.1) | 0 (0) |
| Widow | 26 (22.8) | 3 (12) |
| Religion, n (%) | ||
| Catholic | 111 (97.4) | 23 (92) |
| Jehovah witness | 2 (1.8) | 0 (0) |
| Agnostic | 1 (0.9) | 2 (8) |
| Profession, n (%) | ||
| Self-employed | 1 (0.9) | 0 (0) |
| Manager | 1 (0.9) | 0 (0) |
| Retired | 112 (98.2) | 25 (100) |
| Household, n (%) | ||
| 1 | 27 (23.7) | 3 (12) |
| 2 | 51 (44.7) | 17 (68) |
| 3 | 25 (21.9) | 2 (8) |
| 4 | 7 (6.1) | 1 (4) |
| 5 | 2 (1.8) | 2 (8) |
| 6 | 1 (0.9) | 0 (0) |
| 11 | 1 (0.9) | 0 (0) |
| sd: standard deviation |
| Baseline | Six months later | |||||
|---|---|---|---|---|---|---|
| Scales | Patients (n=114) | Controls (n=25) |
Mann-Whitney’s p-value with Bonferroni correction for multiple testing (33 tests)* |
Patients (n=90) | Controls (n=17) |
Mann-Whitney’s p-value with Bonferroni correction for multiple testing (33 tests)* |
| med (IIQ), min-max | med (IIQ), min-max | med (IIQ), min-max | med (IIQ), min-max | |||
|
HADS Depression ( 8 – 10: mild symptoms) |
9 (6; 10), 0 -15 | 1 (0; 2), 0 -5 | <0.001 | 8 (3; 9), 0 -14 | 1 (0.5; 2), 0 -3 | <0.001 |
|
HADS Anxiety ( 8 – 10: mild symptoms) |
8 (5; 10), 1 -19 | 1 (0.5; 2), 0 -4 | <0.001 | 7 (3; 9), 2 -14 | 1 (0; 2), 0 -2 | <0.001 |
| MMS | 28 (26; 29), 11 -30 | 30 (29; 30), 25 -30 | <0.001 | 28,5 (27; 30), 15 -30 | 30 (30;30 ), 28 -30 | 0.001 |
| CDT | 9 (7; 9.5), 1 -10 | 10 (9.5; 10), 5 -10 | <0.001 | 9,25 (7,9; 9,5), 1 -10 | 10 (9,5; 10), 9 -10 | 0.002 |
| UCLAs | 36.5 (20; 46), 16 -64 | 22 (17; 27.5), 16 -31 | 0.001 | 33 (20; 41,3), 16 -60 | 19 (16.5; 22.5), 16 -25 | 0.007 |
| MAT | 5.86 (5.25; 6), 3.71-6 | 6 (5.4; 6), 5-6 | 1 | 5.86 (5.43; 6), 3.71-6 | 5.86 (5.57; 6), 5.29-6 | 1 |
| BI | 100 (100; 100), 70 -100 | 100 (100; 100), 100 -100 | 1 | 100 (100; 100), 75 -100 | 100 (100; 100), 100 -100 | 1 |
| YATEs | 83.5 (51.5; 95.25), 3 -104 | 52 (30; 80.5), 2 -103 | 0.288 | 86 (41; 97,5), 3 -104 | 55 (23,5; 80,5), 0 -103 | 0.590 |
| WATEs (patient’s decision/will) | 4 (2.75; 4.75), 1 -5 | 3.25 (2.25; 4), 1 -5 | 1 | 4 (2,4; 4,5), 1 -5 | 4 (2; 4), 1 -5 | 1 |
| WATEs (Doctor’s decision/assessment) | 2.75 (1.5; 3.875), 1 -5 | 2 (1.5; 2.5), 1 -4 | 0.612 | 2,33 (1,7; 3,6), 1 -5 | 2 (2; 2), 1 -3 | 1 |
| MDMQ | ||||||
| Self-esteem (max = 12) | 8 (5; 10), 1-12 | 10 (8; 11), 6-12 | <0.001 | 8 (5,8; 10), 1 -12 | 11 (8;11,5), 6 – 12 | 0.315 |
| Vigilance (max = 12) | 10 (6; 12), 0-12 | 12 (10; 12), 2 -12 | 1 | 11 (8; 12), 0 -12 | 12 (10; 12), 3 -12 | 1 |
| Buck Passing (max = 12) | 6 (2; 11), 0-12 | 3 (1.5; 6), 0 -12 | 0.514 | 5 (2; 10), 0 -12 | 4 (1; 7), 0 -9 | 1 |
| Procrastination (max = 10) | 3 (1; 6.25), 0-10 | 3 (1; 4), 0 -9 | 1 | 3 (1; 6), 0 -10 | 3 (1; 4.5), 0 -9 | 1 |
| Hypervigilance (max = 10) | 6 (3.75; 8), 0-10 | 4 (2; 5), 0 -10 | 0.144 | 5,5 (3; 8), 0 -10 | 4 (3; 5,5), 0 -7 | 1 |
| NEO-FFI | ||||||
| Neuroticism | 31 (20; 36.25); 2-47 | 16 (12; 19.5), 4 -28 | <0.001 | 28,5 (18; 34), 4 -41 | 14 (13; 20), 11 -25 | <0.001 |
| Extraversion | 19.5 (16; 25.25), 8-44 | 31 (26; 33), 17 -36 | <0.001 | 20,5 (17; 26), 9 -39 | 29 (26,5; 33), 20 -36 | <0.001 |
| Openness | 12 (7; 19), 3-39 | 23 (18.5; 27.5), 6 -33 | <0.001 | 14 (10; 19), 3 -35 | 23 (18,5; 26,5), 14 -35 | <0.001 |
| Agreeableness | 33 (30; 35), 18-41 | 33 (29.5; 36.5), 20 -41 | 1 | 32,5 (30; 34), 19 -38 | 33 (30; 34,5), 24 -36 | 1 |
| Conscientiousness | 33.5 (31; 36), 4-46 | 36 (34; 39.5), 31 -45 | 0.016 | 34 (31; 36), 12 -39 | 36 (35; 37,5), 28 -41 | 0.064 |
| IRI | ||||||
| Perspective Taking | 3.17 (2; 3.67), 0.5-4 | 2.5 (1.5; 3.3), 1 -4 | 1 | 3,17 (1,7; 3,8), 0 -4 | 1,67 (1,17;3,34), 1 – 3,83 | 1 |
| Empathic Concern | 3.33 (2.63; 3.83), 1.3-4 | 3.2 (2.4; 3.6), 1.5 -4 | 1 | 3,42 (2,8; 3,8), 1,7 -4 | 2,83 (2,50;3,25), 1,67 – 3,83 | 1 |
| Personal Distress | 2.83 (1.83; 3.33), 0-4.2 | 1.7 (0.8; 2.3), 0 -3 | <0.001 | 2,75 (2; 3,3), 0,5 -4 | 1,5 (1;2,09), 0,33 – 2,67 | <0.001 |
| Fantasy | 1.5 (0.67; 2.33), 0-3.7 | 1.7 (1.2; 2.3), 0.3 -3.3 | 1 | 1,5 (0,5; 2,2), 0 -3,7 | 1,5 (1,09;1,67), 0,50 – 3,33 | 1 |
| SF36v2 | ||||||
| physical functioning | 90 (65; 95), 10-100 | 95 (92.5; 100), 60 -100 | <0.001 | 90 (70; 90), 10 -95 | 95 (90; 95), 50 -100 | 0.005 |
| physical role | 93.75 (62.5; 100), 12.5-100 | 100 (100; 100), 75 -100 | 0.012 | 100 (75; 100), 6,3 -100 | 100 (100; 100), 100 -100 | 0.026 |
| pain | 74 (62; 84), 0-100 | 84 (62; 100), 51 -100 | 1 | 84 (62; 100), 12 -100 | 84 (74; 100), 62 -100 | 1 |
| general health | 38.5 (30; 50), 15-95 | 67 (51; 73.5), 35 -100 | <0.001 | 37,5 (28,8; 52), 10 -87 | 67 (56; 74,5), 30 -95 | <0.001 |
| vitality | 37.5 (25; 62.5), 6.25-93.75 | 75 (71.9; 81.3), 56.25 -93.75 | <0.001 | 43,75 (31,3; 56,3), 0 -87,5 | 75 (69; 81), 69 -100 | <0.001 |
| social function | 50 (25; 87.5), 0-100 | 100 (81.3; 100), 62.5 -100 | <0.001 | 62,5 (25; 90,6), 0 -100 | 100 (100; 100), 75 -100 | <0.001 |
| emotional role | 75 (50; 100), 0-100 | 100 (100; 100), 83.33 -100 | <0.001 | 91,67 (58,3; 100), 25 -100 | 100 (100; 100), 100 -100 | 0.003 |
| mental health | 50 (35; 70), 5-100 | 90 (80; 90), 65 -100 | <0.001 | 67,5 (50; 85), 15 -95 | 90 (85; 90), 55 -100 | 0.003 |
| TARS | 7 (4; 10), 2-18 | 3 (2; 3), 2-8 | <0.001 | 5,5 (3; 7), 3 -16 | 3 (2; 3), 2 -3 | <0.001 |
|
min-minimum; max-maximum; med-median; IIQ – interquartile range [1ºQ;3ºQ]; * Mann-Whitney test bilateral p-value; bold: significant p-values (p<0.05). HADS: hospital anxiety and depression scale; MMS: mini-mental-state; CDT: clock drawing test; UCLALs: UCLA loneliness scale; MARS: medication adherence rating scale; B.I.: Barthel index; YATEs: Yara attitude towards euthanasia scale; WATEs: Wasserman attitude towards euthanasia scale; MDMQ: Melbourne decision-making questionnaire; NEO-FFI: NEO five-factor inventory; SF36-v2: short-form health survey - version 2; IRI: interpersonal reactivity index; TASR – tool for assessment of suicide risk. | ||||||
| Correlation with YATEs | ||
|---|---|---|
| Scales and Subscales | Patients | Controls |
| UCLA | -0.181 | 0.159 |
| HADS Depression | -0.100 | 0.280 |
| HADS Anxiety | -0.084 | 0.297 |
| IRI Perspective taking | 0.758** | 0.803** |
| IRI Empathic concern | 0.325** | 0.668** |
| IRI Personal distress | -0.200* | -0.128 |
| IRI Fantasy | 0.378** | 0.368 |
| NEO-FFI Neuroticism | -0.167 | 0.021 |
| NEO-FFI Extroversion | 0.101 | 0.011 |
| NEO-FFI Openness | 0.232* | 0.012 |
| NEO-FFI Agreeableness | 0.223* | 0.188 |
| NEO-FFI Conscientiousness | 0.293** | -0.114 |
| MDMQ Self-esteem | 0.302** | 0.260 |
| MDMQ Vigilance | 0.276** | 0.179 |
| MDMQ Buck passing | -0.280** | -0.384 |
| MDMQ Procrastination | -0.371** | -0.415* |
| MDMQ Hypervigilance | -0.344** | -0.375 |
| SF36v2 Physical functioning | 0.163 | -0.227 |
| SF36v2 Physical role | 0.086 | 0.180 |
| SF36v2 Pain | 0.007 | -0.329 |
| SF36v2 General health | -0.060 | -0.177 |
| SF36v2 Vitality | 0.116 | -0.132 |
| SF36v2 Social function | 0.128 | -0.050 |
| SF36v2 Emotional role | 0.089 | 0.172 |
| SF36v2 Mental health | 0.087 | -0.149 |
| TASR | -0.124 | -0.146 |
|
bold: significant p-values (*p < 0.05; **p < 0.01) HADS: hospital anxiety and depression scale; MMS: mini-mental-state; CDT: clock drawing test; UCLALs: UCLA loneliness scale; MARS: medication adherence rating scale; B.I.: Barthel index; YATEs: Yara attitude towards euthanasia scale; WATEs: Wasserman attitude towards euthanasia scale; MDMQ: Melbourne decision-making questionnaire; NEO-FFI: NEO five-factor inventory; SF36-v2: short-form health survey - version 2; IRI: interpersonal reactivity index; TASR – tool for assessment of suicide risk. | ||
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2024 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
